Lung Cancer - Non-Small Cell News

Share

Lung Cancer - Non-Small Cell News


Dacomitinib Shows Activity in Selected Patients With Advanced Non-Small Cell Lung Cancer (December 9, 2014)

CancerConnect News: In a phase II trial reported in The Lancet Oncology, doctors from Dana Farber Cancer Institute in Boston found that treatment of patients with advanced non–small cell lung cancer... Continue Reading

Xalkori™ (crizotinib) Targeted Therapy More Effective Than Chemotherapy for Treatment of Lung Cancer (December 6, 2014)

A new drug Xalkori™ (crizotinib) is more beneficial than chemotherapy for certain individuals with lung cancer according to new research published in the New England Journal of Medicine. Lung cancer... Continue Reading

Recent Treatment Advancements in Lung Cancer (December 5, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center Facing a lung cancer... Continue Reading

5 Things Women Should Know about Lung Cancer (December 3, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center 1. Smoking causes the... Continue Reading

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung... Continue Reading

FDA Grants Breakthrough Therapy Designation to AP26113 for ALK-Positive NSCLC (October 22, 2014)

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to an investigational agent AP26113 for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small... Continue Reading

Anamorelin May Be First Drug to Treat Cancer Cachexia (October 14, 2014)

A new drug, anamorelin, may be the first ever to effectively improve cancer cachexia. These findings were presented at the 2014 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, September... Continue Reading

Interim Results of X-396 in ALK positive Non-Small Cell Lung Cancer Appear Promising (August 29, 2014)

Preliminary results from a small phase 1 study of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor showed that X-396 is well tolerated and has antitumor activity in patients with ALK positive... Continue Reading

OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine (August 13, 2014)

Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition of its online support communities, TheGIConnection,TheRAConnection, and Cancer Connect, as valuable resources for... Continue Reading

Gilotrif combined with Erbitux Benefits Non-Small Cell Lung Cancer Patients Resistant to EGFR Inhibitors (August 5, 2014)

Researchers recently reported that a combination of the epidermal growth factor receptor (EGFR) targeted agents Gilotrif® (afatinib) and Erbitux® (cetuximab) were able to effectively shrink EGFR positive... Continue Reading

More Lung Cancer - Non-Small Cell News

Latest Lung Cancer - Non-Small Cell News By Stage


Screening/Prevention

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung cancer into focus, it’s time to increase public... Continue Reading

Lung Cancer Screening with Low-Dose CT Scan May Lead to Overdiagnosis (December 26, 2013)

Screening for lung cancer with low-dose CT scan may lead to overdiagnosis, according to the results of a study published in JAMA Internal Medicine. Lung cancer is the leading cause of cancer death among both men and women in the United States. The disease... Continue Reading

USPSTF Recommends Lung Cancer Screening in High-Risk Individuals (August 23, 2013)

The U.S. Preventive Services Task Force (USPSTF) recommends screening people who are at high risk for lung cancer with annual low-dose CT scans, which can prevent a substantial number of lung cancer-related deaths. This is a grade B draft recommendation. Lung... Continue Reading

Screening Could Reduce Lung Cancer Mortality (April 24, 2013)

Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers could potentially avert approximately 12,000 lung cancer deaths each year in the United States, according to the results of a study... Continue Reading

Hormone Replacement Therapy in Newly Menopausal Women May Carry More Benefit Than Risk (October 26, 2012)

Hormone replacement therapy for newly menopausal women may not be as risky as once believed, according to the results of a study presented at the 23rd annual meeting of the North American Menopause Society in Orlando, Florida in October 2012.[1] In fact,... Continue Reading

More Screening/Prevention Lung Cancer - Non-Small Cell

Stages I-IIIA

Xalkori™ (crizotinib) Targeted Therapy More Effective Than Chemotherapy for Treatment of Lung Cancer (December 6, 2014)

A new drug Xalkori™ (crizotinib) is more beneficial than chemotherapy for certain individuals with lung cancer according to new research published in the New England Journal of Medicine. Lung cancer is the leading cause of cancer death in the U.S.... Continue Reading

Recent Treatment Advancements in Lung Cancer (December 5, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center Facing a lung cancer diagnosis? It is important to know the details of... Continue Reading

5 Things Women Should Know about Lung Cancer (December 3, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center 1. Smoking causes the deadliest form of cancer. Lung cancer is the second... Continue Reading

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung cancer into focus, it’s time to increase public... Continue Reading

Preoperative Chemotherapy Improves Survival in NSCLC (May 2, 2014)

Pre-operative (neoadjuvant) chemotherapy for non-small cell lung cancer (NSCLC) is associated with a significant reduction in the risk of death, according to the results of a meta-analysis published in The Lancet. Lung cancer remains the leading cause... Continue Reading

More Stages I-IIIA Lung Cancer - Non-Small Cell

Stages IIIB-IV

Dacomitinib Shows Activity in Selected Patients With Advanced Non-Small Cell Lung Cancer (December 9, 2014)

CancerConnect News: In a phase II trial reported in The Lancet Oncology, doctors from Dana Farber Cancer Institute in Boston found that treatment of patients with advanced non–small cell lung cancer (NSCLC) with EGFR mutations or clinical characteristics... Continue Reading

Xalkori™ (crizotinib) Targeted Therapy More Effective Than Chemotherapy for Treatment of Lung Cancer (December 6, 2014)

A new drug Xalkori™ (crizotinib) is more beneficial than chemotherapy for certain individuals with lung cancer according to new research published in the New England Journal of Medicine. Lung cancer is the leading cause of cancer death in the U.S.... Continue Reading

Recent Treatment Advancements in Lung Cancer (December 5, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center Facing a lung cancer diagnosis? It is important to know the details of... Continue Reading

5 Things Women Should Know about Lung Cancer (December 3, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center 1. Smoking causes the deadliest form of cancer. Lung cancer is the second... Continue Reading

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung cancer into focus, it’s time to increase public... Continue Reading

More Stages IIIB-IV Lung Cancer - Non-Small Cell

Recurrent

Dacomitinib Shows Activity in Selected Patients With Advanced Non-Small Cell Lung Cancer (December 9, 2014)

CancerConnect News: In a phase II trial reported in The Lancet Oncology, doctors from Dana Farber Cancer Institute in Boston found that treatment of patients with advanced non–small cell lung cancer (NSCLC) with EGFR mutations or clinical characteristics... Continue Reading

Xalkori™ (crizotinib) Targeted Therapy More Effective Than Chemotherapy for Treatment of Lung Cancer (December 6, 2014)

A new drug Xalkori™ (crizotinib) is more beneficial than chemotherapy for certain individuals with lung cancer according to new research published in the New England Journal of Medicine. Lung cancer is the leading cause of cancer death in the U.S.... Continue Reading

Recent Treatment Advancements in Lung Cancer (December 5, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center Facing a lung cancer diagnosis? It is important to know the details of... Continue Reading

5 Things Women Should Know about Lung Cancer (December 3, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center 1. Smoking causes the deadliest form of cancer. Lung cancer is the second... Continue Reading

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung cancer into focus, it’s time to increase public... Continue Reading

More Recurrent Lung Cancer - Non-Small Cell

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS